« Corporate/ Company Law (Mondaq) The new Therapeutic Goods Amendment Bill | Main | FDA Approvals - IMPAX Comments on Wyeth's Lawsuit Related to Generic Versions of »

FDA Approvals - National Lipid Association Statin Study: Required Liver Monitoring Unnecessary (PR


National Lipid Association Statin Study: Required Liver Monitoring Unnecessary (PR Newswire via Yahoo! Finance)
In the most comprehensive, rigorous, non- governmental analysis of statins ever undertaken, the National Lipid Association confirmed the safety profile and benefits of cholesterol- lowering statin therapy.

A Changing Prescription for Biotechnology (CNW Group via Yahoo! Finance)
Twenty years ago the first annual analysis on the biotechnology industry -- Biotech 86: At the Crossroads -- described an industry that was just 10 years into its development and comprised of around 700 companies concentrated in the San Francisco and Boston areas.

Protox Therapeutics Grants Stock Options (CNW Group via Yahoo! Finance)
Protox Therapeutics Inc. announced today that they have granted 705,000 options pursuant to its previously approved stock option plan. The options were granted to various employees at an exercise price of $0.52.
 

©2006 FDA-News.com. All rights reserved.